2025年3月18日周二，Schrodinger Inc（NASDAQ: SDGR）在2025年KeyBanc年度医疗保健论坛上进行了演讲。在首席执行官Rami Fareed的带领下，讨论重点围绕公司创新的计算机辅助药物研发平台，强调了其进展和挑战。尽管公司去年的财务表现超出预期，但在平衡内部和合作项目方面仍面临持续性任务。

制药技术公司Schrodinger, Inc. (NASDAQ: SDGR )周一宣布任命Bridget van Kralingen加入董事会，即刻生效。该公司市值为15.4亿美元。根据 InvestingPro 数据显示，公司保持强劲的流动性，流动比率为3.31，资产负债表上现金多于债务，但在过去十二个月面临盈利能力挑战，EBITDA为负2.03亿美元。Van ...

2025年3月4日， Schrodinger（SDGR）披露1笔公司内部人交易情况。高管Porges Geoffrey Craig于2025年3月3日卖出5491股。 Schrodinger, ...

Jenny Herman, the Senior Vice President and Controller at Schrodinger, Inc. (NASDAQ:SDGR), recently sold 859 shares of the company's common stock. The shares were sold at a price of $24.43 each ...

Fans have discovered many humorous Starfield Easter eggs, including the XL-069 Interloper and The Colander in the Schrodinger System. The Schrodinger System is a nod to the physicist's experiment ...

Despite a decline in total revenue, Schrodinger Inc (SDGR) showcases robust software performance and strategic collaborations for future growth. NEW YORK, February 20, 2025--Schrödinger ...

Xpeng (XPEV) and Schrodinger (SDGR) are climbing 5% and 3.3%, respectively, today after Nasdaq.com reported that institutions had acquired many more shares in the companies than they had sold in ...

Schrodinger demonstrated solid performance in Q4 2024, with total revenue for the year reaching $288 million, a significant increase from $217 million in 2023. The company experienced robust ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sarepta Therapeutics (SRPT – Research Report), ...